{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:51:19Z","timestamp":1787863879719,"version":"build-2784847793"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Youth Science Foundation of Peking Union Medical College Hospital","award":["pumch201911867"],"award-info":[{"award-number":["pumch201911867"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-B-114 and 2022-PUMCH-A-026"],"award-info":[{"award-number":["2022-PUMCH-B-114 and 2022-PUMCH-A-026"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-B-114 and 2022-PUMCH-A-026"],"award-info":[{"award-number":["2022-PUMCH-B-114 and 2022-PUMCH-A-026"]}]},{"name":"Chinese Natural Science Foundation","award":["82270405"],"award-info":[{"award-number":["82270405"]}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["20220484031"],"award-info":[{"award-number":["20220484031"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Growth hormone-secreting pituitary neuroendocrine tumors (GH-PitNETs) arise from the anterior pituitary gland and constitute 20\u201330% of all PitNETs, representing a significant subset of functional pituitary tumors. Despite their prevalence, the precise mechanisms underlying the development of these tumors remain elusive due to the complex pathophysiology of pituitary neoplasia. To investigate the potential role of the gut microbiome in GH-PitNETs, we conducted a comprehensive study involving 16S rRNA gene sequencing and metabolomics analysis of fecal and serum samples from 20 GH-PitNET patients and 30 healthy controls at Peking Union Medical College Hospital. Our findings revealed a distinct gut microbiota profile in GH-PitNET patients compared to healthy individuals, characterized by dysbiosis with increased abundance of <jats:italic>Bacteroides<\/jats:italic> and decreased abundance of <jats:italic>Blautia<\/jats:italic> and <jats:italic>Bifidobacterium<\/jats:italic>. Notably, alterations in specific bacterial taxa, including <jats:italic>Intestinibacter bartlettii<\/jats:italic>, <jats:italic>Fusicatenibacter faecihominis<\/jats:italic>, and <jats:italic>Massilioclostridium<\/jats:italic>, were observed in GH-PitNET patients. Concomitantly, serum metabolomics analysis identified 154 differentially abundant metabolites in GH-PitNET patients, with significant enrichment in pathways related to tryptophan metabolism. Among these metabolites, 3-indoleacetic acid (IAA) exhibited a obvious change, suggesting its potential research value for disease processing of GH-PitNETs. To further elucidate the mechanistic link between the gut microbiome and GH-PitNETs, we conducted in vitro and in vivo experiments, our results demonstrated that IAA could promote the proliferation of GH3 cells and significantly enhance growth hormone secretion by activating the cAMP pathway. These findings collectively suggest that gut microbiota dysbiosis may contribute to in the development and progression of GH-PitNETs by contributing to metabolic disturbances.<\/jats:p>","DOI":"10.1038\/s41598-025-07812-x","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T12:19:20Z","timestamp":1751890760000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Multi-omics study reveals gut microbiota dysbiosis and tryptophan metabolism alterations in GH-PitNET progression"],"prefix":"10.1038","volume":"15","author":[{"given":"Jifang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"key":"7812_CR1","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1001\/jama.2023.5444","volume":"329","author":"NA Tritos","year":"2023","unstructured":"Tritos, N. A. & Miller, K. K. Diagnosis and management of pituitary adenomas: A review. JAMA 329, 1386\u20131398. https:\/\/doi.org\/10.1001\/jama.2023.5444 (2023).","journal-title":"JAMA"},{"key":"7812_CR2","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s11102-020-01057-9","volume":"23","author":"L Riccio","year":"2020","unstructured":"Riccio, L., Donofrio, C. A., Tomacelli, G., De Blasi, R. & Melatini, A. Ectopic GH-secreting pituitary adenoma of the clivus: Systematic literature review of a challenging tumour. Pituitary 23, 457\u2013466. https:\/\/doi.org\/10.1007\/s11102-020-01057-9 (2020).","journal-title":"Pituitary"},{"key":"7812_CR3","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1172\/jci39375","volume":"119","author":"S Melmed","year":"2009","unstructured":"Melmed, S. Acromegaly pathogenesis and treatment. J. Clin. Investig. 119, 3189\u20133202. https:\/\/doi.org\/10.1172\/jci39375 (2009).","journal-title":"J. Clin. Investig."},{"key":"7812_CR4","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/s42003-022-04272-1","volume":"5","author":"A Yamato","year":"2022","unstructured":"Yamato, A. et al. Proteogenomic landscape and clinical characterization of GH-producing pituitary adenomas\/somatotroph pituitary neuroendocrine tumors. Commun. Biol. 5, 1304. https:\/\/doi.org\/10.1038\/s42003-022-04272-1 (2022).","journal-title":"Commun. Biol."},{"key":"7812_CR5","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s00262-021-03080-6","volume":"71","author":"D Nie","year":"2022","unstructured":"Nie, D. et al. The intestinal flora of patients with GHPA affects the growth and the expression of PD-L1 of tumor. Cancer Immunol. Immunother. 71, 1233\u20131245. https:\/\/doi.org\/10.1007\/s00262-021-03080-6 (2022).","journal-title":"Cancer Immunol. Immunother."},{"key":"7812_CR6","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1093\/neuonc\/noaa084","volume":"22","author":"C Shi","year":"2020","unstructured":"Shi, C. et al. BRD4 as a therapeutic target for nonfunctioning and growth hormone pituitary adenoma. Neuro. Oncol. 22, 1114\u20131125. https:\/\/doi.org\/10.1093\/neuonc\/noaa084 (2020).","journal-title":"Neuro. Oncol."},{"key":"7812_CR7","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s11427-018-9320-4","volume":"61","author":"Q Liu","year":"2018","unstructured":"Liu, Q. et al. Role of EGFL7\/EGFR-signaling pathway in migration and invasion of growth hormone-producing pituitary adenomas. Sci. China. Life Sci. 61, 893\u2013901. https:\/\/doi.org\/10.1007\/s11427-018-9320-4 (2018).","journal-title":"Sci. China. Life Sci."},{"key":"7812_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.brainresbull.2020.04.018","volume":"161","author":"Q Du","year":"2020","unstructured":"Du, Q. et al. Comprehensive circular RNA profiling reveals that hsa_circ_0001368 is involved in growth hormone-secreting pituitary adenoma development. Brain Res. Bull. 161, 65\u201377. https:\/\/doi.org\/10.1016\/j.brainresbull.2020.04.018 (2020).","journal-title":"Brain Res. Bull."},{"key":"7812_CR9","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s12020-022-03155-z","volume":"78","author":"M Wang","year":"2022","unstructured":"Wang, M. et al. Global changes in chromatin accessibility and transcription in growth hormone-secreting pituitary adenoma. Endocrine 78, 329\u2013342. https:\/\/doi.org\/10.1007\/s12020-022-03155-z (2022).","journal-title":"Endocrine"},{"key":"7812_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2019.07.013","volume":"215","author":"Y Xiong","year":"2020","unstructured":"Xiong, Y. et al. Exosomal hsa-miR-21-5p derived from growth hormone-secreting pituitary adenoma promotes abnormal bone formation in acromegaly. Transl. Res. J. Lab. Clin. Med. 215, 1\u201316. https:\/\/doi.org\/10.1016\/j.trsl.2019.07.013 (2020).","journal-title":"Transl. Res. J. Lab. Clin. Med."},{"key":"7812_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0284949","volume":"18","author":"DW Tucker","year":"2023","unstructured":"Tucker, D. W. et al. Validation of Myc-Associated Protein X (MAX) regulation in growth hormone secreting and nonfunctional pituitary adenoma. PLoS ONE 18, e0284949. https:\/\/doi.org\/10.1371\/journal.pone.0284949 (2023).","journal-title":"PLoS ONE"},{"key":"7812_CR12","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1007\/s40618-021-01510-x","volume":"44","author":"H Yin","year":"2021","unstructured":"Yin, H. et al. Potential biomarkers and lncRNA-mRNA regulatory networks in invasive growth hormone-secreting pituitary adenomas. J. Endocrinol. Invest. 44, 1947\u20131959. https:\/\/doi.org\/10.1007\/s40618-021-01510-x (2021).","journal-title":"J. Endocrinol. Invest."},{"key":"7812_CR13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ijdevneu.2018.03.009","volume":"67","author":"T Lu","year":"2018","unstructured":"Lu, T. et al. Expression of the long non-coding RNA H19 and MALAT-1 in growth hormone-secreting pituitary adenomas and its relationship to tumor behavior. Int. J. Dev. Neurosci. Off. J. Int. Soc. Dev. Neurosci. 67, 46\u201350. https:\/\/doi.org\/10.1016\/j.ijdevneu.2018.03.009 (2018).","journal-title":"Int. J. Dev. Neurosci. Off. J. Int. Soc. Dev. Neurosci."},{"key":"7812_CR14","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1210\/clinem\/dgab652","volume":"107","author":"M Chang","year":"2022","unstructured":"Chang, M. et al. METTL3-mediated RNA m6A hypermethylation promotes tumorigenesis and GH secretion of pituitary somatotroph adenomas. J. Clin. Endocrinol. Metab. 107, 136\u2013149. https:\/\/doi.org\/10.1210\/clinem\/dgab652 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"7812_CR15","doi-asserted-by":"publisher","first-page":"1142494","DOI":"10.3389\/fendo.2023.1142494","volume":"14","author":"M Chang","year":"2023","unstructured":"Chang, M. et al. Exosomal RNAs in the development and treatment of pituitary adenomas. Front. Endocrinol. 14, 1142494. https:\/\/doi.org\/10.3389\/fendo.2023.1142494 (2023).","journal-title":"Front. Endocrinol."},{"key":"7812_CR16","doi-asserted-by":"publisher","first-page":"e2291","DOI":"10.1210\/clinem\/dgac128","volume":"107","author":"C Ji","year":"2022","unstructured":"Ji, C. et al. The p300 inhibitor A-485 exerts antitumor activity in growth hormone pituitary adenoma. J. Clin. Endocrinol. Metab. 107, e2291\u2013e2300. https:\/\/doi.org\/10.1210\/clinem\/dgac128 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"7812_CR17","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2017.200","author":"Q Liu","year":"2018","unstructured":"Liu, Q. et al. Attenuation of EGFL7 expression inhibits growth hormone-producing pituitary adenomas growth and invasion. Hum. Gene Ther. https:\/\/doi.org\/10.1089\/hum.2017.200 (2018).","journal-title":"Hum. Gene Ther."},{"key":"7812_CR18","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00425-21","volume":"10","author":"B Lin","year":"2022","unstructured":"Lin, B. et al. Characteristics of gut microbiota in patients with GH-secreting pituitary adenoma. Microbiol. Spectr. 10, e0042521. https:\/\/doi.org\/10.1128\/spectrum.00425-21 (2022).","journal-title":"Microbiol. Spectr."},{"key":"7812_CR19","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1186\/s12967-023-04582-w","volume":"21","author":"X Zhou","year":"2023","unstructured":"Zhou, X. et al. Leveraging circulating microbiome signatures to predict tumor immune microenvironment and prognosis of patients with non-small cell lung cancer. J. Transl. Med. 21, 800. https:\/\/doi.org\/10.1186\/s12967-023-04582-w (2023).","journal-title":"J. Transl. Med."},{"key":"7812_CR20","doi-asserted-by":"publisher","first-page":"6485","DOI":"10.3390\/ijms22126485","volume":"22","author":"F Fianchi","year":"2021","unstructured":"Fianchi, F., Liguori, A., Gasbarrini, A., Grieco, A. & Miele, L. Nonalcoholic fatty liver disease (NAFLD) as model of gut-liver axis interaction: From pathophysiology to potential target of treatment for personalized therapy. Int. J. Mol. Sci. 22, 6485. https:\/\/doi.org\/10.3390\/ijms22126485 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"7812_CR21","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41591-022-01779-2","volume":"28","author":"EM Park","year":"2022","unstructured":"Park, E. M. et al. Targeting the gut and tumor microbiota in cancer. Nat. Med. 28, 690\u2013703. https:\/\/doi.org\/10.1038\/s41591-022-01779-2 (2022).","journal-title":"Nat. Med."},{"key":"7812_CR22","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1053\/j.gastro.2023.10.012","volume":"166","author":"J Yang","year":"2024","unstructured":"Yang, J. et al. High soluble fiber promotes colorectal tumorigenesis through modulating gut microbiota and metabolites in mice. Gastroenterology 166, 323-337.e327. https:\/\/doi.org\/10.1053\/j.gastro.2023.10.012 (2024).","journal-title":"Gastroenterology"},{"key":"7812_CR23","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00018-022-04278-2","volume":"79","author":"T Re\u017een","year":"2022","unstructured":"Re\u017een, T. et al. The role of bile acids in carcinogenesis. Cell. Mol. Life Sci. CMLS 79, 243. https:\/\/doi.org\/10.1007\/s00018-022-04278-2 (2022).","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"7812_CR24","doi-asserted-by":"publisher","first-page":"119732","DOI":"10.1016\/j.cca.2024.119732","volume":"560","author":"X Guo","year":"2024","unstructured":"Guo, X. et al. Gut microbiota and serum metabolite signatures along the colorectal adenoma-carcinoma sequence: Implications for early detection and intervention. Clin. Chimi. Acta Int. J. Clin. Chem. 560, 119732. https:\/\/doi.org\/10.1016\/j.cca.2024.119732 (2024).","journal-title":"Clin. Chimi. Acta Int. J. Clin. Chem."},{"key":"7812_CR25","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s12072-022-10299-7","volume":"16","author":"R Shen","year":"2022","unstructured":"Shen, R. et al. Abnormal bile acid-microbiota crosstalk promotes the development of hepatocellular carcinoma. Hep. Intl. 16, 396\u2013411. https:\/\/doi.org\/10.1007\/s12072-022-10299-7 (2022).","journal-title":"Hep. Intl."},{"key":"7812_CR26","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.7150\/thno.68611","volume":"12","author":"J Cui","year":"2022","unstructured":"Cui, J. et al. Annexin-A1 deficiency attenuates stress-induced tumor growth via fatty acid metabolism in mice: An Integrated multiple omics analysis on the stress- microbiome-metabolite-epigenetic-oncology (SMMEO) axis. Theranostics 12, 3794\u20133817. https:\/\/doi.org\/10.7150\/thno.68611 (2022).","journal-title":"Theranostics"},{"key":"7812_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155099","volume":"126","author":"W Zhang","year":"2024","unstructured":"Zhang, W. et al. Modulation of cellular metabolism and alleviation of bacterial dysbiosis by Aconiti Lateralis Radix Praeparata in non-small cell lung cancer treatment. Phytomed. Int. J. Phytother. Phytopharmacol. 126, 155099. https:\/\/doi.org\/10.1016\/j.phymed.2023.155099 (2024).","journal-title":"Phytomed. Int. J. Phytother. Phytopharmacol."},{"key":"7812_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41522-023-00472-7","volume":"10","author":"Q Tang","year":"2024","unstructured":"Tang, Q. et al. Endogenous Coriobacteriaceae enriched by a high-fat diet promotes colorectal tumorigenesis through the CPT1A-ERK axis. NPJ Biofilms Microbiomes 10, 5. https:\/\/doi.org\/10.1038\/s41522-023-00472-7 (2024).","journal-title":"NPJ Biofilms Microbiomes"},{"key":"7812_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155385","volume":"128","author":"K Cai","year":"2024","unstructured":"Cai, K. et al. Xianlian Jiedu Decoction alleviates colorectal cancer by regulating metabolic profiles, intestinal microbiota and metabolites. Phytomed. Int. J. Phytother. Phytopharmacol. 128, 155385. https:\/\/doi.org\/10.1016\/j.phymed.2024.155385 (2024).","journal-title":"Phytomed. Int. J. Phytother. Phytopharmacol."},{"key":"7812_CR30","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41598-018-37664-7","volume":"9","author":"T Kov\u00e1cs","year":"2019","unstructured":"Kov\u00e1cs, T. et al. Cadaverine, a metabolite of the microbiome, reduces breast cancer aggressiveness through trace amino acid receptors. Sci. Rep. 9, 1300. https:\/\/doi.org\/10.1038\/s41598-018-37664-7 (2019).","journal-title":"Sci. Rep."},{"key":"7812_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"key":"7812_CR32","doi-asserted-by":"publisher","first-page":"8787","DOI":"10.3748\/wjg.v21.i29.8787","volume":"21","author":"SM Jandhyala","year":"2015","unstructured":"Jandhyala, S. M. et al. Role of the normal gut microbiota. World J. Gastroenterol. 21, 8787\u20138803. https:\/\/doi.org\/10.3748\/wjg.v21.i29.8787 (2015).","journal-title":"World J. Gastroenterol."},{"key":"7812_CR33","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/4441022a","volume":"444","author":"RE Ley","year":"2006","unstructured":"Ley, R. E., Turnbaugh, P. J., Klein, S. & Gordon, J. I. Microbial ecology: Human gut microbes associated with obesity. Nature 444, 1022\u20131023. https:\/\/doi.org\/10.1038\/4441022a (2006).","journal-title":"Nature"},{"key":"7812_CR34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1136\/gutjnl-2015-309618","volume":"65","author":"D Vandeputte","year":"2016","unstructured":"Vandeputte, D. et al. Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut 65, 57\u201362. https:\/\/doi.org\/10.1136\/gutjnl-2015-309618 (2016).","journal-title":"Gut"},{"key":"7812_CR35","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1136\/gutjnl-2018-317609","volume":"68","author":"Y Wan","year":"2019","unstructured":"Wan, Y. et al. Effects of dietary fat on gut microbiota and faecal metabolites, and their relationship with cardiometabolic risk factors: A 6-month randomised controlled-feeding trial. Gut 68, 1417\u20131429. https:\/\/doi.org\/10.1136\/gutjnl-2018-317609 (2019).","journal-title":"Gut"},{"key":"7812_CR36","doi-asserted-by":"publisher","first-page":"6528","DOI":"10.1038\/ncomms7528","volume":"6","author":"Q Feng","year":"2015","unstructured":"Feng, Q. et al. Gut microbiome development along the colorectal adenoma-carcinoma sequence. Nat. Commun. 6, 6528. https:\/\/doi.org\/10.1038\/ncomms7528 (2015).","journal-title":"Nat. Commun."},{"key":"7812_CR37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1053\/j.gastro.2019.03.049","volume":"157","author":"R Pittayanon","year":"2019","unstructured":"Pittayanon, R. et al. Gut microbiota in patients with irritable bowel syndrome-a systematic review. Gastroenterology 157, 97\u2013108. https:\/\/doi.org\/10.1053\/j.gastro.2019.03.049 (2019).","journal-title":"Gastroenterology"},{"key":"7812_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40168-017-0248-8","volume":"5","author":"M Pammi","year":"2017","unstructured":"Pammi, M. et al. Intestinal dysbiosis in preterm infants preceding necrotizing enterocolitis: A systematic review and meta-analysis. Microbiome 5, 31. https:\/\/doi.org\/10.1186\/s40168-017-0248-8 (2017).","journal-title":"Microbiome"},{"key":"7812_CR39","doi-asserted-by":"publisher","first-page":"13537","DOI":"10.1038\/s41598-017-13601-y","volume":"7","author":"NM Vogt","year":"2017","unstructured":"Vogt, N. M. et al. Gut microbiome alterations in Alzheimer\u2019s disease. Sci. Rep. 7, 13537. https:\/\/doi.org\/10.1038\/s41598-017-13601-y (2017).","journal-title":"Sci. Rep."},{"key":"7812_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/nu12051474","author":"F Magne","year":"2020","unstructured":"Magne, F. et al. The firmicutes\/bacteroidetes ratio: A relevant marker of gut dysbiosis in obese patients?. Nutrients https:\/\/doi.org\/10.3390\/nu12051474 (2020).","journal-title":"Nutrients"},{"key":"7812_CR41","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41586-020-2193-0","volume":"581","author":"C Campbell","year":"2020","unstructured":"Campbell, C. et al. Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells. Nature 581, 475\u2013479. https:\/\/doi.org\/10.1038\/s41586-020-2193-0 (2020).","journal-title":"Nature"},{"key":"7812_CR42","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/s41467-023-36981-4","volume":"14","author":"B Tang","year":"2023","unstructured":"Tang, B. et al. Gut microbiota alters host bile acid metabolism to contribute to intrahepatic cholestasis of pregnancy. Nat. Commun. 14, 1305. https:\/\/doi.org\/10.1038\/s41467-023-36981-4 (2023).","journal-title":"Nat. Commun."},{"key":"7812_CR43","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/0960-0760(92)90333-e","volume":"43","author":"DJ Waxman","year":"1992","unstructured":"Waxman, D. J. Regulation of liver-specific steroid metabolizing cytochromes P450: Cholesterol 7\u03b1-hydroxylase, bile acid 6\u03b2-hydroxylase, and growth hormone-responsive steroid hormone hydroxylases. J. Steroid Biochem. Mol. Biol. 43, 1055\u20131072. https:\/\/doi.org\/10.1016\/0960-0760(92)90333-e (1992).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"7812_CR44","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0026-0495(95)90231-7","volume":"44","author":"Z Laron","year":"1995","unstructured":"Laron, Z., Avitzur, Y. & Klinger, B. Carbohydrate metabolism in primary growth hormone resistance (Laron syndrome) before and during insulin-like growth factor-I treatment. Metab. Clin. Exp. 44, 113\u2013118. https:\/\/doi.org\/10.1016\/0026-0495(95)90231-7 (1995).","journal-title":"Metab. Clin. Exp."},{"key":"7812_CR45","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","volume":"18","author":"M Platten","year":"2019","unstructured":"Platten, M., Nollen, E. A. A., R\u00f6hrig, U. F., Fallarino, F. & Opitz, C. A. Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond. Nat. Rev. Drug Discovery 18, 379\u2013401. https:\/\/doi.org\/10.1038\/s41573-019-0016-5 (2019).","journal-title":"Nat. Rev. Drug Discovery"},{"key":"7812_CR46","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.coi.2020.12.001","volume":"70","author":"A Fiore","year":"2021","unstructured":"Fiore, A. & Murray, P. J. Tryptophan and indole metabolism in immune regulation. Curr. Opin. Immunol. 70, 7\u201314. https:\/\/doi.org\/10.1016\/j.coi.2020.12.001 (2021).","journal-title":"Curr. Opin. Immunol."},{"key":"7812_CR47","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.cmet.2023.06.004","volume":"35","author":"C Xue","year":"2023","unstructured":"Xue, C. et al. Tryptophan metabolism in health and disease. Cell Metab. 35, 1304\u20131326. https:\/\/doi.org\/10.1016\/j.cmet.2023.06.004 (2023).","journal-title":"Cell Metab."},{"key":"7812_CR48","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/s12276-023-01028-7","volume":"55","author":"SK Seo","year":"2023","unstructured":"Seo, S. K. & Kwon, B. Immune regulation through tryptophan metabolism. Exp. Mol. Med. 55, 1371\u20131379. https:\/\/doi.org\/10.1038\/s12276-023-01028-7 (2023).","journal-title":"Exp. Mol. Med."},{"key":"7812_CR49","doi-asserted-by":"publisher","first-page":"bqaa026","DOI":"10.1210\/endocr\/bqaa026","volume":"161","author":"EA Jensen","year":"2020","unstructured":"Jensen, E. A. et al. Growth hormone deficiency and excess alter the gut microbiome in adult male mice. Endocrinology 161, bqaa026. https:\/\/doi.org\/10.1210\/endocr\/bqaa026 (2020).","journal-title":"Endocrinology"},{"key":"7812_CR50","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.3390\/ijms22062973","volume":"22","author":"W Roth","year":"2021","unstructured":"Roth, W., Zadeh, K., Vekariya, R., Ge, Y. & Mohamadzadeh, M. Tryptophan metabolism and gut-brain homeostasis. Int. J. Mol. Sci. 22, 2973. https:\/\/doi.org\/10.3390\/ijms22062973 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"7812_CR51","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1038\/s41467-018-05470-4","volume":"9","author":"HM Roager","year":"2018","unstructured":"Roager, H. M. & Licht, T. R. Microbial tryptophan catabolites in health and disease. Nat. Commun. 9, 3294. https:\/\/doi.org\/10.1038\/s41467-018-05470-4 (2018).","journal-title":"Nat. Commun."},{"key":"7812_CR52","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1101\/gad.276733.115","volume":"30","author":"M Petruzzelli","year":"2016","unstructured":"Petruzzelli, M. & Wagner, E. F. Mechanisms of metabolic dysfunction in cancer-associated cachexia. Genes Dev. 30, 489\u2013501. https:\/\/doi.org\/10.1101\/gad.276733.115 (2016).","journal-title":"Genes Dev."},{"key":"7812_CR53","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","volume":"21","author":"ZE Stine","year":"2022","unstructured":"Stine, Z. E., Schug, Z. T., Salvino, J. M. & Dang, C. V. Targeting cancer metabolism in the era of precision oncology. Nat. Rev. Drug. Discov. 21, 141\u2013162. https:\/\/doi.org\/10.1038\/s41573-021-00339-6 (2022).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"7812_CR54","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1172\/jci120844","volume":"128","author":"Y Zhu","year":"2018","unstructured":"Zhu, Y. et al. Emerging evidence for targeting mitochondrial metabolic dysfunction in cancer therapy. J. Clin. Investig. 128, 3682\u20133691. https:\/\/doi.org\/10.1172\/jci120844 (2018).","journal-title":"J. Clin. Investig."},{"key":"7812_CR55","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1158\/2159-8290.Cd-22-1325","volume":"13","author":"TM Robinson","year":"2023","unstructured":"Robinson, T. M. & Levine, R. L. Oncogenic IDH1 mutation imparts therapeutically targetable metabolic dysfunction in multiple tumor types. Cancer Discov. 13, 266\u2013268. https:\/\/doi.org\/10.1158\/2159-8290.Cd-22-1325 (2023).","journal-title":"Cancer Discov."},{"key":"7812_CR56","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2203894119","volume":"119","author":"W Chen","year":"2022","unstructured":"Chen, W. et al. Gut flora disequilibrium promotes the initiation of liver cancer by modulating tryptophan metabolism and up-regulating SREBP2. Proc. Natl. Acad Sci. U. S. A. 119, e2203894119. https:\/\/doi.org\/10.1073\/pnas.2203894119 (2022).","journal-title":"Proc. Natl. Acad Sci. U. S. A."},{"key":"7812_CR57","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1111\/pbi.12105","volume":"11","author":"JG Dubouzet","year":"2013","unstructured":"Dubouzet, J. G., Matsuda, F., Ishihara, A., Miyagawa, H. & Wakasa, K. Production of indole alkaloids by metabolic engineering of the tryptophan pathway in rice. Plant Biotechnol. J. 11, 1103\u20131111. https:\/\/doi.org\/10.1111\/pbi.12105 (2013).","journal-title":"Plant Biotechnol. J."},{"key":"7812_CR58","doi-asserted-by":"publisher","first-page":"5742","DOI":"10.3390\/ijms24065742","volume":"24","author":"A Tsuji","year":"2023","unstructured":"Tsuji, A. et al. The tryptophan and kynurenine pathway involved in the development of immune-related diseases. Int. J. Mol. Sci. 24, 5742. https:\/\/doi.org\/10.3390\/ijms24065742 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"7812_CR59","first-page":"117","volume":"19","author":"I Flor\u00e9n","year":"1980","unstructured":"Flor\u00e9n, I. & Hansson, H. C. Investigations into whether 5-hydroxytryptamine is a neurotransmitter in the retina of rabbit and chicken. Invest. Ophthalmol. Vis. Sci. 19, 117\u2013125 (1980).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"7812_CR60","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","volume":"23","author":"A Agus","year":"2018","unstructured":"Agus, A., Planchais, J. & Sokol, H. Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe 23, 716\u2013724. https:\/\/doi.org\/10.1016\/j.chom.2018.05.003 (2018).","journal-title":"Cell Host Microbe"},{"key":"7812_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1882927","volume":"13","author":"F Hosseinkhani","year":"2021","unstructured":"Hosseinkhani, F. et al. The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases. Gut Microbes 13, 1\u201322. https:\/\/doi.org\/10.1080\/19490976.2021.1882927 (2021).","journal-title":"Gut Microbes"},{"key":"7812_CR62","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.1038\/s41467-024-47868-3","volume":"15","author":"N Venkateswaran","year":"2024","unstructured":"Venkateswaran, N. et al. Tryptophan fuels MYC-dependent liver tumorigenesis through indole 3-pyruvate synthesis. Nat. Commun. 15, 4266. https:\/\/doi.org\/10.1038\/s41467-024-47868-3 (2024).","journal-title":"Nat. Commun."},{"key":"7812_CR63","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.immuni.2022.01.006","volume":"55","author":"K Hezaveh","year":"2022","unstructured":"Hezaveh, K. et al. Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity. Immunity 55, 324-340.e328. https:\/\/doi.org\/10.1016\/j.immuni.2022.01.006 (2022).","journal-title":"Immunity"},{"key":"7812_CR64","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1080\/10408398.2019.1598334","volume":"60","author":"M Sun","year":"2020","unstructured":"Sun, M., Ma, N., He, T., Johnston, L. J. & Ma, X. Tryptophan (Trp) modulates gut homeostasis via aryl hydrocarbon receptor (AhR). Crit. Rev. Food Sci. Nutr. 60, 1760\u20131768. https:\/\/doi.org\/10.1080\/10408398.2019.1598334 (2020).","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"7812_CR65","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1530\/erc-12-0322","volume":"20","author":"ML Jaffrain-Rea","year":"2013","unstructured":"Jaffrain-Rea, M. L. et al. Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations. Endocr. Relat. Cancer 20, 753\u2013766. https:\/\/doi.org\/10.1530\/erc-12-0322 (2013).","journal-title":"Endocr. Relat. Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07812-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07812-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07812-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T12:19:21Z","timestamp":1751890761000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07812-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7812"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-07812-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,7]]},"assertion":[{"value":"9 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24261"}}